Cargando…
P1278: ACTIVATION OF THE NECROPTOSIS PATHWAY PLAYS A ROLE IN SYNERGISM WITH COMBINATION OF THE IAP ANTAGONIST, TOLINAPANT AND HYPOMETHYLATING AGENTS (HMA) IN IN VITRO MODELS OF T-CELL LYMPHOMA (TCL).
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429711/ http://dx.doi.org/10.1097/01.HS9.0000847976.26425.20 |
| _version_ | 1784779543713677312 |
|---|---|
| author | Manavalan, J. S. Pal, I. Pursley, A. Ward, G. Smyth, T. Sims, M. Feith, D. Loughran, T. P. O’Connor, O. A. Marchi, E. |
| author_facet | Manavalan, J. S. Pal, I. Pursley, A. Ward, G. Smyth, T. Sims, M. Feith, D. Loughran, T. P. O’Connor, O. A. Marchi, E. |
| author_sort | Manavalan, J. S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429711 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94297112022-08-31 P1278: ACTIVATION OF THE NECROPTOSIS PATHWAY PLAYS A ROLE IN SYNERGISM WITH COMBINATION OF THE IAP ANTAGONIST, TOLINAPANT AND HYPOMETHYLATING AGENTS (HMA) IN IN VITRO MODELS OF T-CELL LYMPHOMA (TCL). Manavalan, J. S. Pal, I. Pursley, A. Ward, G. Smyth, T. Sims, M. Feith, D. Loughran, T. P. O’Connor, O. A. Marchi, E. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429711/ http://dx.doi.org/10.1097/01.HS9.0000847976.26425.20 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Manavalan, J. S. Pal, I. Pursley, A. Ward, G. Smyth, T. Sims, M. Feith, D. Loughran, T. P. O’Connor, O. A. Marchi, E. P1278: ACTIVATION OF THE NECROPTOSIS PATHWAY PLAYS A ROLE IN SYNERGISM WITH COMBINATION OF THE IAP ANTAGONIST, TOLINAPANT AND HYPOMETHYLATING AGENTS (HMA) IN IN VITRO MODELS OF T-CELL LYMPHOMA (TCL). |
| title | P1278: ACTIVATION OF THE NECROPTOSIS PATHWAY PLAYS A ROLE IN SYNERGISM WITH COMBINATION OF THE IAP ANTAGONIST, TOLINAPANT AND HYPOMETHYLATING AGENTS (HMA) IN IN VITRO MODELS OF T-CELL LYMPHOMA (TCL). |
| title_full | P1278: ACTIVATION OF THE NECROPTOSIS PATHWAY PLAYS A ROLE IN SYNERGISM WITH COMBINATION OF THE IAP ANTAGONIST, TOLINAPANT AND HYPOMETHYLATING AGENTS (HMA) IN IN VITRO MODELS OF T-CELL LYMPHOMA (TCL). |
| title_fullStr | P1278: ACTIVATION OF THE NECROPTOSIS PATHWAY PLAYS A ROLE IN SYNERGISM WITH COMBINATION OF THE IAP ANTAGONIST, TOLINAPANT AND HYPOMETHYLATING AGENTS (HMA) IN IN VITRO MODELS OF T-CELL LYMPHOMA (TCL). |
| title_full_unstemmed | P1278: ACTIVATION OF THE NECROPTOSIS PATHWAY PLAYS A ROLE IN SYNERGISM WITH COMBINATION OF THE IAP ANTAGONIST, TOLINAPANT AND HYPOMETHYLATING AGENTS (HMA) IN IN VITRO MODELS OF T-CELL LYMPHOMA (TCL). |
| title_short | P1278: ACTIVATION OF THE NECROPTOSIS PATHWAY PLAYS A ROLE IN SYNERGISM WITH COMBINATION OF THE IAP ANTAGONIST, TOLINAPANT AND HYPOMETHYLATING AGENTS (HMA) IN IN VITRO MODELS OF T-CELL LYMPHOMA (TCL). |
| title_sort | p1278: activation of the necroptosis pathway plays a role in synergism with combination of the iap antagonist, tolinapant and hypomethylating agents (hma) in in vitro models of t-cell lymphoma (tcl). |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429711/ http://dx.doi.org/10.1097/01.HS9.0000847976.26425.20 |
| work_keys_str_mv | AT manavalanjs p1278activationofthenecroptosispathwayplaysaroleinsynergismwithcombinationoftheiapantagonisttolinapantandhypomethylatingagentshmaininvitromodelsoftcelllymphomatcl AT pali p1278activationofthenecroptosispathwayplaysaroleinsynergismwithcombinationoftheiapantagonisttolinapantandhypomethylatingagentshmaininvitromodelsoftcelllymphomatcl AT pursleya p1278activationofthenecroptosispathwayplaysaroleinsynergismwithcombinationoftheiapantagonisttolinapantandhypomethylatingagentshmaininvitromodelsoftcelllymphomatcl AT wardg p1278activationofthenecroptosispathwayplaysaroleinsynergismwithcombinationoftheiapantagonisttolinapantandhypomethylatingagentshmaininvitromodelsoftcelllymphomatcl AT smytht p1278activationofthenecroptosispathwayplaysaroleinsynergismwithcombinationoftheiapantagonisttolinapantandhypomethylatingagentshmaininvitromodelsoftcelllymphomatcl AT simsm p1278activationofthenecroptosispathwayplaysaroleinsynergismwithcombinationoftheiapantagonisttolinapantandhypomethylatingagentshmaininvitromodelsoftcelllymphomatcl AT feithd p1278activationofthenecroptosispathwayplaysaroleinsynergismwithcombinationoftheiapantagonisttolinapantandhypomethylatingagentshmaininvitromodelsoftcelllymphomatcl AT loughrantp p1278activationofthenecroptosispathwayplaysaroleinsynergismwithcombinationoftheiapantagonisttolinapantandhypomethylatingagentshmaininvitromodelsoftcelllymphomatcl AT oconnoroa p1278activationofthenecroptosispathwayplaysaroleinsynergismwithcombinationoftheiapantagonisttolinapantandhypomethylatingagentshmaininvitromodelsoftcelllymphomatcl AT marchie p1278activationofthenecroptosispathwayplaysaroleinsynergismwithcombinationoftheiapantagonisttolinapantandhypomethylatingagentshmaininvitromodelsoftcelllymphomatcl |